Webb8 maj 2024 · To the Editors, In a recent paper, Occhipinti and Pastorelli reported their experience in managing inflammatory bowel disease (IBD) patients during the … Webb26 mars 2024 · Background: The effectiveness of anti-TNF or ustekinumab (UST) as a second-line biologic after vedolizumab (VDZ) failure has not yet been described. Aims and methods: In this retrospective multicenter cohort study, We aim to investigate the effectiveness of anti-TNF and UST as second-line therapy in patients with Crohn's …
Insights into the biology and therapeutic implications of TNF and
Webb1 aug. 2024 · Background: Our understanding of coronavirus disease 2024 (COVID-19) and its implications for patients with inflammatory bowel diseases (IBD) is rapidly evolving. … Webb13 apr. 2024 · Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC) and comprises a chronic gastrointestinal tract disorder characterized by hyperactive and dysregulated immune responses to environmental factors, including gut microbiota and dietary components. An imbalance of the intestinal microbiota may … shenandoah electric coop
Risk of Lymphoma Associated with Anti-TNF Therapy in Patients …
WebbInflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy Sleep Apnea: Assessment of Sleep … WebbIntroduction. Inflammatory bowel disease (IBD) and rheumatic disease (RD) are chronic disorders characterized by inflammation in the gastrointestinal tract and the joints or … Webb13 apr. 2024 · Clinically, the goals of IBD treatment are to induce and maintain disease remission and mucosal healing, and then improve the patient's quality of life. Tumour necrosis factor (TNF)-α is a proinflammatory cytokine and plays an essential role in the induction and maintenance of inflammation in the intestine [ [4] ]. spotify profile pics